pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Anti-inflammatory · news · pharmadog
← back to Anti-inflammatory
News mentioning Anti-inflammatory
17
stories
1d
Kolon TissueGene cuts 37 US staffers after Phase 3 fail
biospace
2d
Regeneron ends eye disease study due to antibody's safety profile
biospace
2d
Regeneron ends eye disease study due to antibody's safety profile
biospace
11d
Arpeggio plays final chord as biotech disbands on poor prospects for Nrf2 program
fiercebiotech
14d
BioVie shares halve on murky Parkinson’s disease readout
biospace
20d
Novo Nordisk rocked by late-stage cardiovascular drug failure
endpoints
20d
STAT+: Novo Nordisk inflammation-targeting drug misses mark in heart disease study
stat
22d
‘We have what we need to grow:’ Biogen CEO happy to ease off the M&A for a while
fiercebiotech
Jul 21, 26
Novartis stays 'geography-agnostic' in dealmaking amid flurry of China deals
biospace
Jul 15, 26
Cassidy grills Trump nominee on past vaccine comments in heated exchange
stat
Jun 18, 26
cAMPfield lands $180M to build gut disease drug
biopharma dive
Jun 18, 26
Biogen adds more immune drugs in $1B buyout of secretive startup RayThera
biopharma dive
Jun 18, 26
Biogen makes up to $1B deal for secretive anti-inflammatory biotech
endpoints
Jun 16, 26
How supplement use changed over decades
stat
Jun 10, 26
Sanofi stops immune drug trial in latest research setback
biopharma dive
May 18, 26
Regeneron immunotherapy combo comes up short in melanoma trial
biopharma dive
Apr 23, 26
Sanofi posts upbeat sales as R&D pressure builds
biopharma dive
